Additionally, while we tested the Capan-1 xenograft model, a cell line representative of homologous recombination repair deficiency (HRD) due to BRCA2 deletion, other cell lines without an HRD background were not fully addressed in our in vivo model. Here, BRCA2 is linked to hypoparathyroidism-retardation-dysmorphism syndrome.